HOME >> BIOLOGY >> NEWS
Promising anti-TB compound finally can be synthesized with ease

BUFFALO, N.Y. -- An efficient new strategy for synthesizing a natural marine product, which shows promising anti-tuberculosis activity but cannot be efficiently synthesized using conventional chemistry, is being reported by University at Buffalo organic chemists online on Feb. 10 in Angewandte Chemie International Edition.

The UB researchers' method synthesizes the compound in days rather than months, requires fewer steps and is capable of producing gram quantities.

The UB chemists describe the direct synthesis in the laboratory of the natural product isolated from the Pseudopterogorgia corals. They now are applying the synthesis method to other members of this class of compounds called diterpenes, some of which also have activity against TB and are potential anti-inflammatory and anticancer agents.

"We're poised now to make them all and to develop new analogs as potential medications," said Huw Davies, Ph.D., Larkin Professor of Organic Chemistry at UB and co-author.

Once thought to be nearly eliminated, tuberculosis is again among the world's most-deadly infectious diseases, killing between 2 million and 3 million people each year.

Its reemergence has been triggered partly by AIDS, which makes an individual 30 times more likely to develop TB, and by multidrug resistance caused by difficulties in getting patients to comply with long treatment regimens.

Davies explained that the family of marine compounds called diterpenes was discovered and demonstrated to have anti-TB activity in 2000, but as with most natural products, so little could be extracted from the marine organism that full biological evaluation was not possible.

To circumvent the problem, chemists have concentrated their efforts on producing the compounds in the laboratory.

Davies explained that the compounds have proven remarkably difficult to synthesize not because they're so complex, but because
'"/>

Contact: Ellen Goldbaum
goldbaum@buffalo.edu
716-645-5000 x1415
University at Buffalo
10-Feb-2005


Page: 1 2

Related biology news :

1. Promising protein may prevent eye damage in premature babies
2. Tailored treatments: Promising designer drug provides new insight into cancer biology
3. Promising antiobesity drug fails to produce clinically meaningful weight loss
4. Promising preclinical results with live attenuated H5N1 vaccines
5. Promising new research on hereditary diseases
6. Promising cell protein may play role in infection and dry eye
7. Promising results in the battle against incurable ALS muscle disease
8. Promising new preventative treatment option for population of men at high risk of prostate cancer
9. A compound from olive-pomace oil gets 80 percent slowing down of HIV spread
10. New compound effectively treats fungal infections
11. Natural compound and exercise boost memory in mice

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/23/2020)... ... January 23, 2020 , ... ... USA initiative, the Advanced Regenerative Manufacturing Institute (ARMI). Headquartered in Manchester, New ... consortium of over 100 partner organizations from industry, government, academia and the ...
(Date:1/22/2020)... HOUSTON (PRWEB) , ... January ... ... specializes in integrating cold chain operations, developing transport validation strategies, supporting ... recognition by both Inc. 5000 and the Houston Business Journal as a ...
(Date:1/7/2020)... FORT WORTH, Texas (PRWEB) , ... January 07, ... ... of its 2020 prospectus. The Lifecycle prospectus features not just part numbers like ... business, it’s manufacturing facilities, the industries it supports, and that is all linked ...
Breaking Biology News(10 mins):
(Date:2/10/2020)... ... , ... R3 Medical Training announced it is now registering for its next ... course is hands on involving real patients and stem cell biologics, with every attendee ... Cell Training Course has received rave reviews from attendees, who love the hands on ...
(Date:2/5/2020)... ... 05, 2020 , ... Rare Disease Day® , held the last day ... Rare Disorders (NORD), to raise awareness amongst the general public and decision-makers about rare ... “Behind The Mystery” rare disease series will be shining the light on ...
(Date:2/3/2020)... BUDAPEST, Hungary and CAMBRIDGE, Mass. (PRWEB) , ... ... ... headquartered in Budapest with US offices in Cambridge, MA, announce that OmniType, the ... Access Program (EAP) from today. OmniType is a best-in-class product featuring locus-multiplexing and ...
(Date:1/28/2020)... ... January 28, 2020 , ... ... announced the release of Genedata Expressionist ® 13.5 at the 2020 ... Multi-Attribute Methods (MAM) for characterizing and monitoring the quality of biopharmaceuticals throughout ...
Breaking Biology Technology:
Cached News: